Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding

NCT02158182 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

88

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatic Encephalopathy

Interventions

DRUG: Lactulose
DRUG: L-ornithine L-aspartate
DRUG: Rifaximin
DRUG: Placebo

Sponsor

Hospital General de Mexico